347-PXN-0209

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name347-PXN-0209
Drug Alias Namemcl-1 inhibitors (Priaxon)myeloid leukemia cell differentiation protein inhibitors (Priaxon)347-PXN-0209
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInduced myeloid leukemia cell differentiation protein Mcl-1 inhibitors
TargetsInduced myeloid leukemia cell differentiation protein Mcl-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPriaxon Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPriaxon Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A